Herantis Pharma | Wednesday, September 27th | 0 comments

Patient recruitment started and first patient consented in the CDNF Phase I-II clinical study

http://herantis.com/release/herantis-pharma-has-initiated-patient-recruitment-and-consented-first-patient-in-cdnf-study-in-parkinsons-disease/